DSIP
Delta Sleep-Inducing Peptide (DSIP) is a naturally occurring neuromodulator first isolated from rabbit brain tissue in 1977. It has been studied for its role in promoting delta-wave sleep patterns, modulating stress hormone responses, and supporting the body's natural circadian rhythm architecture.
Talk with an Aspire clinician about whether DSIP may be appropriate for your health goals.
Text Us NowDelta Sleep-Inducing Peptide - A Natural Sleep Neuromodulator
DSIP (Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu) is a nine amino acid neuropeptide originally isolated from the cerebral venous blood of rabbits during induced sleep by Schoenenberger and Monnier in 1977. It is found naturally in the human hypothalamus and pituitary gland, and has been identified in the bloodstream at varying concentrations that fluctuate with circadian rhythms. DSIP belongs to a class of endogenous sleep-regulatory substances that the body produces to help govern the sleep-wake cycle.
Research spanning several decades has examined DSIP's effects on sleep architecture, particularly its relationship with slow-wave (delta) sleep stages. Clinical studies, primarily conducted in European research centers, have investigated DSIP in patients with insomnia and disrupted sleep patterns. Additional research has explored its role in stress-hormone modulation, pain perception, and withdrawal symptom management. The peptide appears to function more as a sleep modulator than a sedative, meaning it may help normalize disrupted sleep patterns rather than forcing unconsciousness.
Aspire Rejuvenation offers DSIP through licensed 503A compounding pharmacies for patients whose sleep disruptions have been evaluated and for whom conventional approaches may not have provided adequate results. Our physicians assess sleep quality, stress markers, and hormone levels before determining if DSIP may be an appropriate component of a comprehensive sleep optimization strategy.

Proposed Mechanism of Action
DSIP's mechanism of action is multifaceted and not fully elucidated, which is consistent with its role as a neuromodulatory peptide rather than a compound with a single receptor target. Research suggests it acts on several systems simultaneously. In the hypothalamus, DSIP appears to influence the sleep-promoting neurons of the ventrolateral preoptic area (VLPO) while modulating the activity of wake-promoting orexin neurons. Unlike benzodiazepines or other sedative-hypnotics, DSIP does not appear to suppress neural activity broadly - instead, it seems to shift the balance of sleep-wake neurocircuitry toward sleep-promoting states.
A significant body of research has focused on DSIP's interaction with the stress axis. Studies have demonstrated effects on ACTH and cortisol secretion patterns, suggesting DSIP may help normalize HPA axis activity in individuals experiencing stress-related sleep disruption. Additional research has identified interactions with serotonergic and GABAergic systems, both of which play established roles in sleep regulation. Some studies have also noted DSIP's ability to modulate LH release and interact with opioid systems, suggesting a broader neuroendocrine regulatory role beyond sleep alone.
What DSIP Is Being Explored For
These are the primary areas where DSIP has been studied or discussed in the context of peptide therapy. Research depth varies by area.
How DSIP Is Offered
DSIP is available through Aspire in the following formulations, all compounded by licensed U.S. 503A pharmacies. Your clinician will recommend the appropriate form based on your goals and treatment plan.
Text our team anytime during business hours.
Monday through Friday, 9:30 AM - 6:00 PM.
We're here to help you understand your options.
How Treatment Works
Peptide therapy at Aspire follows a clinician-guided process. DSIP is not available for self-prescribing or anonymous purchase.
Often Explored Alongside DSIP
These compounds are frequently discussed in similar clinical contexts or combined in treatment protocols.
DSIP FAQ
DSIP has been studied in clinical settings since the late 1970s, with research conducted primarily at European institutions. While multiple clinical studies exist, larger-scale controlled trials would strengthen the evidence base. Its mechanism remains an active area of investigation.
Ready to explore DSIP?
Talk with an Aspire clinician about your goals and whether DSIP therapy may be appropriate for you.
Text Us Now

